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Sagittal abdominal diameter: no advantage compared with other
anthropometric measures as a correlate of components of the
metabolic syndrome in elderly from the Hoorn Study13
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Coen DA Stehouwer, Robert J Heine, Giel Nijpels, and Jacob C Seidell
ABSTRACT
Background: The sagittal abdominal diameter has been proposed as
a useful measure by which to estimate abdominal obesity and as
being more strongly related to components of the metabolic syn-
drome than are other anthropometric measures.
Objective: The objective was to study which anthropometric mea-
sure (ie, sagittal abdominal diameter, waist circumference, waist-to-
hip ratio, waist-to-height ratio, or body mass index) is the strongest
correlate of components of the metabolic syndrome (ie, glucose and
lipid concentrations and blood pressure) in the elderly.
Design: The Hoorn Study is a population-based cohort study in older
Dutch men and women. Cross-sectional data were analyzed. Age-
adjusted Pearson correlations of anthropometric measures with com-
ponents of the metabolic syndrome were calculated in 826 subjects
(389 men, 437 women) aged 56–83 y. Analyses were performed
with adjustment for age and stratification for sex and age (65 or
65 y).
Results: No single anthropometric measure was consistently cor-
related more strongly with components of the metabolic syndrome
than were the other measures in either men or women. The associ-
ations were generally stronger in younger subjects than in older
subjects and in women than in men. For example, the correlation
between sagittal abdominal diameter and postload glucose was 0.35
(P 0.001) in younger and 0.14 (P 0.051) in older men, and the
correlation between waist circumference and postload glucose was
0.33 (P 0.001) in older women and 0.14 (P 0.062) in older men.
Conclusion: The use of sagittal abdominal diameter has no ad-
vantages over simpler and more commonly used anthropometric
measures such as the waist circumference in older men and
women. Am J Clin Nutr 2006;84:995–1002.
KEY WORDS Sagittal abdominal diameter, waist circumfer-
ence, hip circumference, waist-to-hip ratio, waist-to-height ratio,
body mass index, fat distribution, metabolic syndrome, elderly
INTRODUCTION
Obesity is associated with a higher risk of cardiovascular dis-
ease (CVD) and diabetes mellitus. Because of the worldwide
increasing prevalence of obesity, it has been projected that, by
2020, chronic diseases such as CVD and diabetes mellitus will
account for almost three-fourths of all deaths (1). Results from
many studies indicate that measures of abdominal fat are better
predictors of CVD and diabetes mellitus than is total adiposity as
assessed by the body mass index (BMI; in kg/m2) in adults (2–9).
The higher risk of CVD and diabetes mellitus associated with
abdominal obesity is usually attributed to greater visceral fat
accumulation (10, 11). With abdominal obesity come myriad
metabolic disturbances such as elevated concentrations of
plasma triacyglycerol, glucose, and insulin; high blood pressure;
and low plasma concentrations of HDL cholesterol. The combi-
nation of these disturbances is often referred to as the metabolic
syndrome (12, 13).
In adult populations, waist-to-hip ratio (WHR) and waist cir-
cumference are the most commonly used indicators of abdominal
adiposity. Waist circumference has been proposed as a better
measure of CVD risk than is WHR, because it correlates more
strongly with visceral fat than does WHR (14, 15). Sagittal ab-
dominal diameter may be an even better predictor of CVD risk
than is waist circumference, because it may be a stronger corre-
late of visceral fat as a result of the movement of subcutaneous fat
to the sides of the waist when the measurement is taken. Several
investigators, however, have identified WHR as a better predic-
tor of CVD and diabetes mellitus than is waist circumference (2,
3, 16, 17). This unexpected result may be due to a relatively
protective role of peripheral fat tissue and muscle mass at the hips
(18, 19).
Aging is associated with a decrease in height (20, 21), a more
central fat distribution (22, 23), and a loss of muscle mass (sar-
copenia) (24). As a result, one should be cautious when inter-
preting associations between anthropometric measures and met-
abolic risk in the elderly.
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Indirect anthropometric estimates of body composition have
proven useful for clinical practice and epidemiologic surveys
because they are simple, noninvasive, and cheap. However, stud-
ies that compare the association between anthropometric vari-
ables and CVD risk factors are scarce, particularly in older sub-
jects. Therefore, the principal aim of this cross-sectional study
was to examine which measure (ie, sagittal abdominal diameter,
waist circumference, WHR, waist-to-height ratio, or BMI) best
reflects the components of the metabolic syndrome in an elderly
population. An additional aim was to examine possible age- or
sex-based differences in the correlations between anthropomet-
ric measures and components of the metabolic syndrome.
SUBJECTS AND METHODS
Subjects
The Hoorn Study is a population-based cohort study of glu-
cose intolerance in a general elderly population in the Nether-
lands. The baseline examination took place from 1989 until 1992
in 2484 white men and women (aged 50–75 y) and was previ-
ously described in detail (25). Between January 1996 and De-
cember 1998, a follow-up examination was conducted after a
mean interval of 6.4 y. Of the initial cohort, 150 persons had died
and 108 had moved away from Hoorn before 1996. One hundred
forty other persons were not invited because of logistic reasons.
Of the remaining 2086 persons who were invited for the
follow-up examination, 1513 (72.5%) participated (8). For the
current study, cross-sectional data from this follow-up examina-
tion were analyzed after the exclusion of subjects who were using
lipid-lowering (n 141), antihypertensive (n 347), or antidi-
abetic (n  28) medication (some subjects had data missing on
1 variable), because medication use may bias the results and
because the anthropometric measurements to predict CVD risk
may be most relevant for persons who are not yet taking medi-
cation. Subjects with missing sagittal abdominal diameter data
(as a result of logistical reasons; n 305) were also excluded. Of
the remaining 840 subjects, 14 had 1 missing metabolic vari-
able [fasting glucose, triacylglycerols, or glycated hemoglobin
(HbA1c)] and were also excluded. Therefore, the analyses were
performed in 826 subjects (389 men and 437 women).
All participants gave written informed consent. The Ethics
Committee of Vrije University Medical Center Amsterdam ap-
proved the design of the study.
Measurements
Weight and height were measured while the subjects were
barefoot and were wearing light clothing only; BMI was calcu-
lated. Sagittal abdominal diameter (in cm) was measured by
using a HoltainKahn abdominal caliper (Holtain Ltd, Crymych,
United Kingdom) while the subjects were in a supine position.
Participants were asked to bend their knees to a 45 ° angle and to
keep their feet flat on the examination table. Sagittal abdominal
diameter (the distance between the abdomen and the back) was
measured as the distance between the blades of the caliper at the
end of normal expiration. In a standing position, waist circum-
ference (in cm) was measured at the level midway between the
lowest rib margin and the iliac crest, and hip circumference (in
cm) was measured at the widest level over the greater trochanters.
The mean value of 2 measurements was used in the analyses.
WHR was calculated as waist circumference divided by hip
circumference, and waist-to-height ratio was calculated as waist
circumference divided by height.
Participants underwent a single 75-g oral-glucose-tolerance
test. Fasting plasma glucose concentration and glucose concen-
tration 2 h after the glucose load were measured in plasma by
using the hexokinase method (Boehringer-Mannheim, Mann-
heim, Germany). HbA1c, an indicator of long-term glucose con-
centrations, was measured by using ion-exchange HPLC. HDL
cholesterol and triacylglycerols were measured by using enzy-
matic techniques (Boehringer-Mannheim).
Blood pressure was measured twice with the use of a random-
zero sphygmomanometer (Hawksley-Gelman, Lancing, United
Kingdom) on the right arm while the subject was sitting. The
average of the 2 measurements was used for analyses. Self-
reported information on the subjects’ current use of lipid-
lowering, antihypertensive, and antidiabetic medications was
obtained by questionnaires.
Statistical analysis
All statistical analyses were performed separately for men and
women because of known differences in body composition.
Means and SDs are presented for normally distributed variables,
and medians and interquartile ranges are presented for variables
with a skewed distribution. The Student’s t test and the Mann-
Whitney U test were used to compare differences between the
sexes and the age groups.
Intercorrelations of the anthropometric measurements ad-
justed for age were examined by using partial Pearson correlation
analysis. Triacylglycerol concentrations were not normally dis-
tributed and were therefore transformed into natural logarithms
for statistical tests. We then examined the associations among
anthropometric measurements (independent variables) and com-
ponents of the metabolic syndrome (dependent variables) by
performing linear regression analysis, with adjustment for age.
Effect modification by age was evaluated by adding product
terms (using the continuous age variable anthropometric vari-
able) to the regression models. Results were stratified by age
(65 or65 y) because some of the associations among anthro-
pometric measurements and components of the metabolic syn-
drome were significantly modified by age. The associations were
also examined by calculating age-adjusted correlations. Because
results were similar for the regression analysis and the correlation
analysis, we present only the correlations. In further analyses, we
also adjusted for BMI to examine the correlations independent of
overall obesity.
To calculate the level of waist circumference or sagittal ab-
dominal diameter at which metabolic variables pass their estab-
lished cutoff values (eg, the level of waist circumference at which
the blood pressure reaches the critical value of 140 mm Hg) and
to ascertain whether these levels are different for the 2 age
groups, we used the age group–specific intercepts and slopes of
the linear regression analyses (with adjustment for age). The
established cutoffs that we used in the regression formulas were
6.1 mmol/L for fasting glucose and 7.8 mmol/L for postload
glucose (26), 1.0 (men) and 1.3 (women) mmol/L for HDL (12),
1.7 mmol/L for triacylglycerol (12), and 140 mm Hg for systolic
and 90 mm Hg for diastolic blood pressure (27). For HbA1c, a
critical value of 6.5% was used. All statistical analyses were
performed by using SPSS for WINDOWS (version 10.1.0; SPSS
Inc, Chicago, IL).
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RESULTS
Characteristics of the study population according to age and
sex are shown in Table 1. As expected, women had a larger hip
circumference, a smaller waist circumference, a lower WHR and
higher HDL-cholesterol and lower fasting glucose concentra-
tions than did men, in both age groups. Significant age-related
differences were also observed: subjects 65 y old were taller
and had a smaller waist circumference, WHR, and waist-to-
height ratio than did subjects 65 y old. In addition, postload
glucose concentrations and systolic blood pressure were substan-
tially higher in older subjects than in their younger counterparts.
Intercorrelations among BMI, sagittal abdominal diameter,
waist circumference, WHR, and waist-to-height ratio adjusted
for age are presented in Table 2. The anthropometric variables
were strongly and significantly correlated with each other in both
sexes and in both age groups (65 or65 y).
Age-adjusted correlations between anthropometric measure-
ments and components of the metabolic syndrome, stratified by
age, are shown in Table 3. No single anthropometric measure
had correlations that were substantially higher than the other anthro-
pometric measures. For several components of the metabolic syn-
drome, but not for postload glucose concentrations, a substantially
stronger correlation with anthropometric measurements was ob-
served inyounger (65y) than inolder (65y)subjects.Generally,
correlations between anthropometric measures and components of
the metabolic syndrome were stronger in women than in men. We
also performed these analyses without excluding subjects who were
taking antidiabetic, antihypertensive, or lipid-lowering medication,
TABLE 1
Characteristics of the study population1
Men
(n 389)
Women
(n 437)
65 y old
(n 196)
65 y old
(n 193)
65 y old
(n 231)
65 y old
(n 206)
Age (y) 60.5 2.392,3 71.0 4.5 60.5 2.33 71.3 4.5
Anthropometric measures
Weight (kg) 81.1 12.04 79.3 10.34 71.1 10.0 71.1 10.5
Height (cm) 176.9 6.23,4 175.6 6.54 165.1 5.73 163.3 6.5
BMI (kg/m2) 25.9 3.3 25.7 2.84 26.1 3.4 26.7 3.7
Sagittal abdominal diameter (cm) 21.0 2.84 21.4 2.5 20.4 2.53 21.4 2.8
Waist girth (cm) 94.1 10.03,4 96.3 8.34 86.4 9.74 89.4 10.9
Hip girth (cm) 99.7 6.44 99.4 5.14 102.3 7.1 103.1 7.6
Waist-to-hip ratio 0.94 0.063,4 0.97 0.064 0.84 0.073 0.87 0.07
Waist-to-height ratio 0.53 0.053 0.55 0.05 0.52 0.063 0.55 0.07
Metabolic variables
Fasting glucose (mmol/L) 5.98 0.764 6.00 0.734 5.72 0.60 5.84 0.83
Postload glucose (mmol/L) 5.53 1.713 5.99 2.224 5.55 1.403 6.48 2.20
HbA1c (%) 5.33 0.51 5.43 0.54 5.36 0.47 5.44 0.56
Triacylglycerol (mmol/L) 1.30 (1.10–1.70)5 1.30 (1.00–1.80) 1.20 (1.00–1.80) 1.30 (1.00–1.70)
HDL cholesterol (mmol/L) 1.20 0.304 1.20 0.344 1.50 0.39 1.49 0.38
Systolic blood pressure (mm Hg) 133.0 18.23 143.8 20.2 134.5 20.63 146.9 21.6
Diastolic blood pressure (mm Hg) 82.0 10.5 81.7 11.4 81.6 10.9 81.0 10.4
1 HbA1c, glycated hemoglobin.
2 x  SD (all such values).
3 Significantly different from other age group by sex, P 0.05 (Student’s t test or, in case of skewed distribution, Mann-Whitney U test).
4 Significantly different from women within an age group, P 0.05 (Student’s t test or, in case of skewed distribution, Mann-Whitney U test).
5 Median; interquartile range in parentheses (all such values).
TABLE 2
Age-adjusted Pearson correlations between anthropometric measures, stratified for age and sex1
Women
BMI SAD WC WHR WHtR
65 y old 65 y old 65 y old 65 y old 65 y old 65 y old 65 y old 65 y old 65 y old 65 y old
Men
BMI — — 0.72 0.70 0.80 0.84 0.42 0.51 0.83 0.87
SAD 0.70 0.61 — — 0.81 0.75 0.58 0.54 0.77 0.71
WC 0.88 0.81 0.79 0.70 — — 0.78 0.80 0.95 0.95
WHR 0.58 0.48 0.64 0.54 0.83 0.81 — — 0.80 0.80
WHtR 0.89 0.83 0.75 0.65 0.94 0.91 0.83 0.82 — —
1 SAD, sagittal abdominal diameter; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio. All correlations were statistically
significant (P 0.001).
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but these exclusions did not materially change the results (data not
shown). The results were also similar for all the other anthropomet-
ric measurements if subjects with missing sagittal abdominal diam-
eter were not excluded from the analyses (data not shown).
The associations between waist circumference and postload
glucose and between sagittal abdominal diameter and postload
glucose are shown in Figure 1. They illustrate a stronger asso-
ciation in younger men and in older women. The association of
WHR with postload glucose had a similar pattern (not shown).
After additional adjustment for BMI, the correlations between
measures of abdominal adiposity and the components of the
metabolic syndrome became considerably weaker (Table 4).
Most anthropometric measures retained statistically significant
correlations, however. An exception was the lack of correlation
between anthropometric measures and blood pressure in the
group aged65 y. No single anthropometric measure was con-
sistently more strongly correlated with components of the met-
abolic syndrome than with the other measures after additional
adjustment for BMI.
Although the correlations were weaker in the group aged65
y, it could be argued that, because they already have less favor-
able values of metabolic variables, subjects in the older age group
will reach critical (high-risk) values of the metabolic variables at
lower levels of abdominal obesity. However, no consistent dif-
ferences between the older and younger age groups were ob-
served in the waist circumference or sagittal abdominal diameter
measurements at which critical values of metabolic variables
were reached (data not shown). For example, elevated fasting
glucose concentrations (ie,6.1 mmol/L) are reached at a lower
waist circumference in younger men (101 cm) than in older men
(103 cm), whereas these concentrations are reached at a higher
waist circumference in younger women (106 cm) than in older
women (104 cm).
DISCUSSION
Few studies have examined the relation between different
anthropometric measures and CVD risk factors in the elderly. As
far as we know, this is the first study to examine and compare all
the simple anthropometric measurements, including sagittal ab-
dominal diameter, in relation to the components of the metabolic
syndrome in an elderly population. We found that no single
anthropometric measure was consistently superior in indicating
unfavorable levels of components of this syndrome. Correlations
were generally stronger in the younger (65 y old) men and
women than in their older (65 y old) counterparts. In addition,
stronger correlations were observed in women than in men.
Even though our data are derived from a cross-sectional study,
the sex- and age-related differences in weight and stature seem to
correspond to those described in some longitudinal studies (28,
29). Our study also confirms the observation that body fat dis-
tribution differs significantly between the sexes in the elderly.
Our results show that the various anthropometric measurements
are significantly associated with components of the metabolic
FIGURE 1. Mean postload glucose concentrations according to tertiles of waist circumference (left) and tertiles of sagittal abdominal diameter (right) in
men (top) and in women (bottom).u, Subjects aged65 y;■, subjects aged65 y. Waist sex age and sagittal abdominal diameter sex age interactions
were statistically significant (P 0.032 and P 0.038, respectively).
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syndrome in a general elderly population but that no single mea-
sure was consistently superior to another. Of all of the anthro-
pometric measurements, the BMI is the most frequently used.
However, the relation between BMI and body fatness is depen-
dent on age (30). Weight may remain stable in the elderly,
whereas fat-free mass decreases (eg, sarcopenia) and fat mass
increases (31). In addition, the body fat distribution changes with
age (from peripheral to abdominal fat distribution), but that
change is not captured by the BMI. Therefore, BMI would be
expected to be a poor indicator of CVD risk in the elderly. In the
population of the current study, however, BMI actually per-
formed well as compared with the other anthropometric mea-
sures. It could be argued that this finding resulted from our
exclusion of subjects who were taking antidiabetic, antihyper-
tensive, or lipid-lowering medication, which left a relatively
healthy population for the current study. However, if these sub-
jects taking medication were not excluded, the results were the
same. Note that the results may be different in even older popu-
lations (75 y old). Moreover, we observed that measures of
abdominal body fatness were still substantially associated
with various other components of the metabolic syndrome
after adjustment for BMI. This finding indicates that the use of
measures of fat distribution may provide useful information in
addition to BMI for the prediction of the metabolic syndrome
in the elderly. In our data, however, BMI does not signifi-
cantly contribute to the metabolic risk if waist circumference
or sagittal abdominal diameter is used (except for blood pres-
sures in women) (data not shown). These results suggest that,
for public health purposes, a sagittal abdominal diameter or a
(more easily obtained) single waist circumference could be
used in the elderly.
The relative utility of various estimates of fat distribution has
been controversial. Some investigators have proposed that waist
circumference is a better indicator of abdominal fat distribution
than is WHR, because it requires only one measurement and is
more highly correlated with visceral fat (14, 15). Sagittal abdom-
inal diameter has been proposed to be even better; however, no
large or consistent difference between sagittal abdominal diam-
eter and waist circumference has been found in relation to vis-
ceral fat (15, 32–35). In men and women somewhat older than
those in the current study (ie, 70 y old), sagittal abdominal
diameter was a better predictor of visceral fat than was waist
circumference, and BMI performed just as well as did waist
circumference (36). Studies comparing all these anthropometric
measures with cardiovascular disease risk rather than with vis-
ceral fat are, however, scarce. In small studies in obese men (37)
and healthy normal-weight men (38), sagittal abdominal diam-
eter was (slightly) more strongly correlated with metabolic vari-
ables than was the waist circumference, WHR, or BMI. In an-
other small study of selected men (of whom 50% had type 2
diabetes and 50% were of Indo-Asian origin), sagittal abdominal
diameter and waist circumference were better predictors of an
adverse metabolic profile than were WHR and BMI (39). A study
including both men and women showed that sagittal abdominal
diameter was slightly but consistently more strongly correlated
with cardiovascular disease risk than were waist circumference,
WHR, and BMI (40), but another study showed both sagittal
abdominal diameter and waist circumference to be more strongly
correlated than was WHR (32). Inconsistency among studies
may be caused by differences between characteristics of the
study populations. All of these studies were performed in rela-
tively young subjects. Only one previous study was performed in
older men and women (aged 67–78 y), and it also found that no
single anthropometric measure was consistently more strongly
correlated with metabolic outcomes than were the others (41).
After adjustment for BMI, that study found that sagittal abdom-
inal diameter and waist circumference were the strongest corre-
lates (41).
In our study, all abdominal anthropometric measures were
correlated with metabolic disturbances, but none was superior
TABLE 4
Age- and BMI-adjusted Pearson correlations between anthropometric measurements and components of the metabolic syndrome stratified for age and sex1
Aged65 y Aged65 y
SAD WC WHR WHtR SAD WC WHR WHtR
Men (n 389)
FPG 0.10 (0.172) 0.20 (0.006) 0.17 (0.021) 0.13 (0.072) 0.16 (0.027) 0.11 (0.152) 0.15 (0.038) 0.09 (0.246)
PLG 0.22 (0.002)2 0.17 (0.021)2 0.15 (0.039)2 0.22 (0.002) 0.08 (0.265) 0.06 (0.446) 0.07 (0.360) 0.13 (0.075)
HbA1c 0.05 (0.481) 0.17 (0.016) 0.16 (0.031)2 0.12 (0.104) 0.11 (0.129) 0.02 (0.802) 0.06 (0.414) 0.03 (0.683)
Ln TG 0.16 (0.026) 0.25 (0.001)2 0.30 (0.001)2 0.26 (0.001)2 0.26 (0.001) 0.04 (0.578) 0.09 (0.213) 0.03 (0.686)
HDL-C 0.12 (0.085) 0.18 (0.013) 0.15 (0.035) 0.12 (0.103) 0.07 (0.330) 0.04 (0.548) 0.06 (0.406) 0.12 (0.113)
SBP 0.25 (0.001) 0.17 (0.018) 0.17 (0.015) 0.13 (0.072) 0.08 (0.248) 0.01 (0.890) 0.08 (0.299) 0.03 (0.671)
DBP 0.18 (0.014) 0.17 (0.020) 0.09 (0.195) 0.07 (0.330) 0.00 (0.972) 0.01 (0.944) 0.01 (0.914) 0.05 (0.511)
Women (n 437)
FPG 0.26 (0.001) 0.20 (0.002) 0.22 (0.001) 0.23 (0.001) 0.18 (0.009) 0.22 (0.002) 0.26 (0.001) 0.21 (0.004)
PLG 0.09 (0.154)2 0.15 (0.029)2 0.24 (0.001)2 0.23 (0.001) 0.16 (0.027) 0.17 (0.018) 0.22 (0.001) 0.15 (0.032)
HbA1c 0.02 (0.765) 0.09 (0.159) 0.05 (0.412) 0.09 (0.191) 0.08 (0.259) 0.16 (0.027) 0.15 (0.031) 0.13 (0.073)
Ln TG 0.30 (0.001) 0.26 (0.001) 0.34 (0.001) 0.28 (0.001) 0.24 (0.001) 0.11 (0.121) 0.26 (0.001) 0.13 (0.058)
HDL-C 0.12 (0.075) 0.16 (0.018)2 0.17 (0.012) 0.11 (0.111) 0.07 (0.348) 0.17 (0.016) 0.28 (0.001) 0.16 (0.027)
SBP 0.05 (0.416)2 0.07 (0.273)2 0.12 (0.062) 0.13 (0.060)2 0.03 (0.711) 0.03 (0.649) 0.07 (0.298) 0.03 (0.660)
DBP 0.05 (0.451)2 0.13 (0.053)2 0.17 (0.009)2 0.15 (0.029)2 0.07 (0.338) 0.07 (0.334) 0.03 (0.645) 0.09 (0.185)
1 P values in parentheses. Men aged65 y, n 196; men aged65 y, n 193; women aged65 y, n 231; women aged65 y, n 206. SAD, sagittal
abdominal diameter; WC, waist circumference; HC, hip circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio, FPG, fasting plasma glucose;
PLG, postload glucose; HbA1c, glycated hemoglobin; Ln TG, ln-transformed triacyglycerol; HDL-C, HDL cholesterol; SBP, systolic blood pressure; DBP,
diastolic blood pressure.
2 Significant effect modification by age in linear regression model, P 0.10.
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to the other in predicting these disturbances, either before or
after adjustment for BMI. Most of the correlations were some-
what stronger in the younger (65 y old) than in the older
(65 y old) subjects, as was found previously (42). This
finding may indicate that, during aging, additional changes
occur in body composition that are not captured by the an-
thropometric measures used. These changes in body compo-
sition may include sarcopenia with concomitant fat accumu-
lation, intermuscular or intramuscular fat accumulation, or
liver fat accumulation, all of which have been shown to be
related to an adverse metabolic profile.
In conclusion, no single anthropometric measure, including
sagittal abdominal diameter, was consistently superior to the
other anthropometric measures in indicating unfavorable levels
of components of the metabolic syndrome in older men and
women. From a public health perspective, it may be advisable to
use the anthropometric measurement that is regarded as the simplest
and most practical, such as the waist circumference, in an elderly
population. Further research should be undertaken to confirm
whether these results also apply to older men and women of other
ethnicities or to more elderly (eg,80 y old) persons.
JM-P and MBS were responsible for the data analyses; JM-P wrote the
draft of the manuscript, and MBS was responsible for the final version;
RMvD, JMD, LMB, CDAS, RJH, GN, and JCS were involved in the pre-
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